Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma

Journal of Orthopaedic Research

Volumn 21, Issue 6, 2003, Pages 1063-1070

  Jiang, Xiaoling ^a   Dutton, Charyl M ^a   Qi, Wen Ning ^b   Block, Joel A ^c   Brodt, Pnina ^d   Durko, Margaret ^d,e   Scully, Sean P ^a  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d ROYAL VICTORIA HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Antisense RNA; Chondrosarcoma; Invasion; Metastasis; MMP 1

Indexed keywords

CELLS; GENES; PROTEINS; RNA; TISSUE;

GENE EXPRESSION;

ORTHOPEDICS;

COLLAGEN TYPE 1; COLLAGENASE 3; COMPLEMENTARY RNA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE;

ARTICLE; BIOLOGICAL THERAPY; CANCER INHIBITION; CANCER INVASION; CANCER RECURRENCE; CHONDROSARCOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRUS; TUMOR CELL;

EID: 0242384076     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00079-2     Document Type: Article

References (44)

1. Ahmad A, Hart IR. Mechanisms of metastasis. Crit Rev Oncol Hematol 1997;26:163-73.
2. Airola K, Karonen T, Vaalamo M, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999; 80:733-43.
3. Arii S, Mori A, Uchida S, et al. Implication of vascular endothelial growth factor in the development and metastasis of human cancers. Hum Cell 1999;12:25-30.
4. Berend KR, Toth AP, Harrelson JM, et al. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 1998;80:11-7.
5. Bohle AS, Kalthoff H. Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 1999;384:133-40.
6. Catalanotto C, Azzalin G, Macino G, Cogoni C. Gene silencing in worms and fungi. Nature 2000;404:245.
7. Chambers AF. The metastatic process: basic research and clinical implications. Oncol Res 1999;11:161-8.
8. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89:1260-70.
9. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189:300-8.
10. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-30.
11. Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs 1997; 15:175-85.
12. Dernburg AF, Zalevsky J, Colaiacovo MP, Villeneuve AM. Transgene-mediated cosuppression in the C. elegans germ line. Genes Dev 2000;14:1578-83.
13. Domeier ME, Morse DP, Knight SW, et al. A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans. Science 2000;289:1928-31.
14. Durko M, Navab R, Shibata HR, Brodt P. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1997;1356:271-80.
15. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
16. Ellerbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. Bioessays 1999;21:940-9.
17. Engers R, Gabbert HE. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000;126:682-92.
18. Fagard M, Boutet S, Morel JB, et al. AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals. Proc Natl Acad Sci USA 2000;97:11650-4.
19. Fang K, Chen MH. Transfection of anti-sense complementary DNA of human epidermal-growth-factor receptor attenuates the proliferation of human non-small-cell-lung-cancer cells. Int J Cancer 1999;81:471-8.
20. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol 1999;43:S3-10.
21. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase-9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996:56:5279-84.
22. Inoue T, Yashiro M, Nishimura S, et al. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int J Mol Med 1999;4:73-7.
23. Kanamori Y, Matsushima M, Minaguchi T, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-7.
24. Kleiner DE. Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999:43:S42-51.
25. Kurschat P, Mauch C. Mechanisms of metastasis. Clin Exp Dermatol 2000;25:482-9.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 1970;227:680-5.
27. Laws HJ, Burdach S, van Kaick B, et al. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report. Strahlenther Onkol 1999;175: 488-94.
28. Marcusson EG, Yacyshyn BR, Shanahan Jr WR, Dean NM. Preclinical and clinical pharmacology of antisense oligonucleotides. Mol Biotechnol 1999;12:1-11.
29. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multi-functional contributors to tumor progression. Mol Med Today 2000;6:149-56.
30. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 2000;5:3-10.
31. Meyer W, Malawer M. Osteosarcoma: clinical features and evolving surgical and chemotherapeutic strategies. Pediatr Clin North Am 1991;38:317-48.
32. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
33. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-61.
34. Pawlak W, Zolnierek J, Sarosiek T, Szczylik C. Antisense therapy in cancer. Cancer Treat Rev 2000;26:333-50.
35. Saeter G, Wiebe T, Wiklund T, et al. Chemotherapy in osteosarcoma the Scandinavian sarcoma group experience. Acta Orthop Scand 1999;70:74-82.
36. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPS) in tumor metastasis. J Biochem (Tokyo) 1996;119: 209-15.
37. Schwartz MA, Venkataraman S, Ghaffari MA, et al. Inhibition of human collagenases by sulfur-based substrate analogs. Biochem Biophys Res Commun 1991;176:173-9.
38. Scully SP, Berend KR, Qi WN, Harrelson JM. Collagenase specificity in chondrosarcoma metastasis. Braz J Med Biol Res 1999;32:885-9.
39. Scully SP, Berend KR, Toth A, et al. Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma. Clin Orthop 2000:291-303.
40. Sharp PA. RNA interference - 2001. Genes Dev 2001;15:485-90.
41. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
42. Uchida A, Myoui A, Araki N, et al. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 1997;79:411-5.
43. Ueda Y, Oda Y, Tsuchiya H, et al. Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Arch A Pathol Anat Histopathol 1990;417:291-7.
44. Ziober BL, Chen YQ, Ramos DM, et al. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ 1999;10:479-90.